JCRB1170 SKNO-1
Cell information
Cell type:general cells (View Pricing Information)
JCRB No. | JCRB1170 | Cell Name | SKNO-1 |
---|---|---|---|
Profile | a GM-CSF dependent cell line with an t8,21 chromosome translocation estabulished from a patient attacked by acute myeloid leukemia(AML) | Other Name | |
Animal | human | Strain | |
Genus | Homo | Species | sapiens |
Sex | M | Age | 22 |
Identity | available | Tissue for Primary Cancer | hemo-lymphocytic |
Case history | acute myeloblastic leukaemia (AML) | Metastasis | No |
Tissue Metastasized | Genetics | t(8;21), monosomy17, p53 mutation. | |
Life Span | infinite | Crisis PDL | |
Morphology | myeloblast | Character | MPO+, CAE+, NBE-. |
Classify | tumor | Established by | |
Registered by | Kawaguchi, R. | Regulation for Distribution | |
Comment | Year | 2006 | |
Medium | RPMI 1640 with 10% Fetal Bovine Serum and 10 ng/ml rhGM-CFS(recombinant human granurocyte-macrophage colonystimulating factor) | Methods for Passages | |
Cell Number on Passage | Race | Japanese | |
CO2 Conc. | 5% | Tissue Sampling | bone marrow |
Tissue Type | myeloblast |
Detection of virus genome fragment by Real-time PCR | |||||||||
---|---|---|---|---|---|---|---|---|---|
Detected DNA Virus | tested | Detected RNA Virus | tested | ||||||
CMV | - | parvoB19 | - | HCV | - | HTLV-1 | - | ||
EBV | - | HBV | - | HIV-1 | - | HTLV-2 | - | ||
HHV6 | - | HTLV-1 | - | HIV-2 | - | HAV | - | ||
HHV7 | - | HTLV-2 | - |
-/negative. +/positive. nt/not tested. (positive (+) does not immediately mean the production of infectious viral particles.) |
|||||
BKV | - | HIV-1 | - | ||||||
JCV | - | HIV-2 | - | ||||||
ADV | - | HPV18 | - | ||||||
Notes |
Reference | |
---|---|
Pubmed id:9029185 | Glucocorticoids induce apoptosis in acute myeloid leukemia cell lines with A t(8;21) chromosome translocation. Miyoshi H,Ohki M,Nakagawa T,Honma Y Leuk Res. 1997 Jan;21(1):45-50 |
Pubmed id:7772516 | Establishment of a myeloid leukaemic cell line (SKNO-1) from a patient with t(8;21) who acquired monosomy 17 during disease progression. Matozaki S,Nakagawa T,Kawaguchi R,Aozaki R,Tsutsumi M,Murayama T,Koizumi T,Nishimura R,Isobe T,Chihara K Br J Haematol. 1995 Apr;89(4):805-11 |
Pubmed id:7972130 | Growth inhibition and induction of differentiation of t(8;21) acute myeloid leukemia cells by the DNA-binding domain of PEBP2 and the AML1/MTG8(ETO)-specific antisense oligonucleotide. Sakakura C,Yamaguchi-Iwai Y,Satake M,Bae SC,Takahashi A,Ogawa E,Hagiwara A,Takahashi T,Murakami A,Makino K Proc Natl Acad Sci U S A. 1994 Nov 22;91(24):11723-7 |
Pubmed id:8136267 | Establishment of a leukaemic cell line from a patient with acquisition of chromosomal abnormalities during disease progression in myelodysplastic syndrome. Nakagawa T,Matozaki S,Murayama T,Nishimura R,Tsutsumi M,Kawaguchi R,Yokoyama Y,Hikiji K,Isobe T,Chihara K Br J Haematol. 1993 Nov;85(3):469-76 |
Pubmed id:2096594 | A case of epidural granulocytic sarcoma preceding acute leukemia. Watanabe M,Sashikata T,Kizaki T,Fujiwara T,Ugai K,Nakagawa T Acta Pathol Jpn. 1990 Dec;40(12):922-6 |
Images |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |